INTRODUCTION
Intracranial aneurysms (IAs) are balloon-like dilations of the intracranial arterial wall in the brain. Rupture of IA causes subarachnoid hemorrhage (SAH), a serious subtype of stroke, which leads to fatality in 50% of the cases and results in significant disability in 30% of the cases (1). The age-and sex-adjusted annual incidence and mortality rates of SAH were 23 and 9 per 100 000 for all ages, respectively, in Japan (1) . The annual rupture risk of IA in Japan is relatively high at 2.7% (2). The incidence of SAH is particularly higher in Finland and Japan than in the rest of the world (1, (3) (4) (5) .
Both environmental and genetic factors are known to be involved in the development of IA, and several studies have indicated that hypertension, hypercholesterolemia, cigarette smoking and female gender are risk factors for IA (6) (7) (8) (9) (10) . Various Mendelian hereditary connective tissue disorders such as autosomal dominant polycystic kidney disease (11) and * To whom correspondence should be addressed at: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Tel: +81 354495372; Fax: +81 354495433; Email: yusuke@ims.u-tokyo.ac.jp type-IV Ehlers-Danlos syndrome (12) are the inherited conditions that increase the risk of IA. Additionally, a positive family history for IA is considered to be an important risk factor, as the incidence of harboring IA for individuals who have at least two affected first-degree relatives was reported to range from 6 to 10% (6, 13, 14) . With the high incidence of familial IA, several susceptible loci which include chromosomes 1p34.3-p36.13 (15) , 7q11 (16), 19q13.3 (17) and Xp22 (18) were successfully identified to be linked to familial IA through the linkage analysis. All this evidence has strongly implied the role of genetic factors contributing to the physiopathology of IAs.
Since there is no clear symptom of IA, identification of risk factors, particularly genetic risk factors, that lead to an increase in the risk of the formation and rupture of IA, which result in aneurysmal subarachnoid hemorrhage (aSAH), is critically essential. With the current advances in biotechnology, it is now feasible to identify common genetic variants that are associated with polygenic diseases by means of genome-wide high-density SNP array. Two genomewide association studies (GWAS) of multiple European populations have successfully identified common variants located on chromosomes 8q12.1, 9p21.3, 10q24.32, 13q13.1 and 18q11.2 that are associated with IA. Notably, these associated loci were successfully replicated in the Japanese population (19, 20) . Because of the complex linkage disequilibrium (LD) structures across different populations and potential interaction between genetic variants and environment factors, it is well known that the effect size of common genetic variants associated with the disease varies among different populations. Although a GWAS of IA in the Japanese population was reported previously, the association was not conclusive due to the lack of validation analysis as well as the insufficient statistical power of the study (21) . Hence, we conducted an independent GWAS of IA with a larger samples size for the identification of genetic variants associated with IA in the Japanese population.
RESULTS
To identify genetic variants associated with susceptibility to IA in the Japanese population, we performed a GWAS, using 1383 aSAH patients and 5484 control (Supplementary Material, Table S1 ) subjects, with Illumina OmniExpress BeadChip Kits that contained 733 202 SNPs. After quality check of the SNP genotyping data, a total of 565 149 autosomal SNPs were used for association analysis (Supplementary Material, Table S2 ).
Principal component analysis (PCA) revealed that all the subjects participating in this study were clustered in the Asian population (Supplementary Material, Fig. S1 ). The detailed PCA analysis on the basis of the genotype information from the cases and controls classified the sample populations mostly into two major clusters consisting of the Ryuukyu cluster (southern islands of Japan) and the Hondo cluster (mainland cluster) (Supplementary Material, Fig. S2 ). To avoid influences of population substructure in the sample populations as well as age and gender biases, the association study was performed by logistic regression analysis with associated eigenvectors, age and gender as covariates.
A quantile-quantile (Q-Q) plot for this GWAS based on 565 149 SNPs is shown in Supplementary Material, Figure  S3 . The genomic inflation factor (l GC ) of the test statistic in this study was 1.055. Since it is known that the l GC value increases with an increase of the sample size, we calculated the l GC value adjusted to a sample size of 1000-which was 1.031, indicating a low possibility of false-positive association by population stratification. We subsequently applied the genomic control method to adjust the P-values and used the adjusted P-values (P GC ) for further analysis. The Manhattan plot shown in Figure 1 Table S3 ). On chromosome 9p21.3, although the previously reported SNP, rs1333040, revealed a P-value of 3.79 × 10
22
, we identified another SNP, rs10757272, on this locus that showed stronger association with IA with a P-value of 7.75 × 10
24
. However, we observed no association with P-values of .0.05 for the five SNPs (rs7542311, rs358345, rs4628172, rs6461176, rs10217224) that were previously indicated in the GWAS in the Japanese population (Supplementary Material, Table S3 ).
To further validate a possible genetic variant(s) associated with IA, we selected a total of 64 SNPs showing suggestive association (P GC , 1 × 10
) with IA. After excluding SNPs that possess LD coefficient (r 2 ) of .0.8 within each LD block, we performed a replication study of 36 SNPs, using an independent set of samples consisting of 1048 IA patients and 7212 controls. In addition, we further analyzed seven previously reported SNPs, rs10958409, rs9298506, rs1333040, rs11191514, rs1980781 rs11661542 and rs10757272, that showed nominal association (P-value of ,0.05) with IA in our first stage.
Among 43 SNPs in the replication study, two SNPs (rs6842241 on 4q31.22, rs10757272 on 9p21.3) were successfully replicated with Bonferroni-corrected P-value of ,1.16 × 10 23 (0.05/43 independent tests) at the replication phase as shown in Table 1 and Supplementary Material, Table S4 . The association of these two SNPs with IA was statistically significant, considering strict multiple testing with the Bonferroni correction. After evaluating the combined association of the discovery GWAS and replication stage using weighted inverse-variance meta-analysis, we identified an SNP, rs6842241, to have achieved the genome-wide significant level of association with IA in the Japanese population, yielding a combined P-value of 9.58 × 10 29 (OR ¼ 1.25; 95% CI ¼ 1.16 -1.34) without any significant heterogeneity (P for heterogeneity ¼ 0.606 with I 2 ¼ 0.0%). This SNP is located within the regulatory region of the EDNRA gene on the chromosome locus 4q31.22. We also identified another EDNRA intronic SNP, rs17612742 (r 2 ¼ 0.99 with rs6842241), from the GWAS to be significantly associated with IA. Imputation analysis of this locus identified two additional SNPs, rs6841581 and rs1878406, with an r 2 -value of .0.8 showing similar levels of association with rs6842241 ( Fig. 2A) .
Human Molecular
Among the previously reported candidate loci (8q11.23, 9p21.3, 10q24.32, 13q13.1 and 18q11.2) associated with IA, the SNPs, rs1333040 and rs10757272 (r 2 ¼ 0.57 with rs1333040), within the CDKN2BAS gene on a 9p21.3 region were replicated their significant association with IA in the Japanese population. In this study, rs10757272 revealed a combined P-value of 1.55 × 10 27 (OR ¼ 1.21; 95% CI ¼ 1.13 -1.30) ( Table 1) . The other SNP, rs1333040, on the same locus was also successfully replicated, but the effect of this variant was less significant with a P-value of 5.56 × 10 Table S4 ). Imputation analysis on the 9p21.3 region indicated that most of the strongly associated SNPs were located at the 3 ′ end of CDKN2BAS (Fig. 2B ). After adjustment for known IA risk factors, which included smoking and hypertension, the association of rs6842241 and rs10757272 with IA remained strong (2. Table S5 ).
Among the SNPs that were previously reported, rs11191514 on 10q24.32 and rs1980781 on 13q13.1 revealed less significant association with IA in the Japanese population; the combined analysis of the two stages showed a P-value of 9.68 × 10 Although the SNP rs671 located in ALDH2 on chromosome 12q24.12 was marginally replicated with a P-value of 5.56 × 10 23 , the meta-analysis combining the two stages revealed stronger association with a P-value of 2.63 × 10 26 (OR ¼ 1.24, 95% CI ¼ 1.15 -1.34). Owing to the functional relevance of this locus to IA, this SNP was considered to be significant in the susceptibility to IA in the Japanese population ( Table 1) .
Identification of novel genetic variants on the EDNRA gene revealed important insights into IA pathogenesis because of the biological function of this gene. Hence, we further investigated the role of genetic variants in the transcriptional level or the protein function. We identified four SNPs in an intron (rs17612742), or an upstream (rs6841581, 1878406 and rs6842241) of EDNRA to be significantly associated with IA through GWAS and imputation analysis. To examine the effect of these SNPs on the transcription, we performed electrophoretic mobility shift assays (EMSAs) and identified allelic differences in the binding affinity of a nuclear protein(s) from HEK293 cells, using the oligonucleotides corresponding to each allele of rs6841581 and rs1878406. The bands corresponding to the susceptible alleles G for rs6841581 and C for rs1878406 appeared to be strong, but those for protective alleles A and T appeared to be weak or undetectable (Fig. 3A) . The different binding affinity between the two alleles for rs6841581 and those for rs1878406 were confirmed 
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by the competition assay in which non-labeled oligonucleotides were added at different concentrations; the increase of the nonlabeled oligonucleotides inhibited the binding of the labeled oligonucleotides in a dose-dependent manner (Fig. 3B ).
To identify whether these SNPs could affect the transcriptional activity of EDNRA, we performed reporter assays by inserting either of the oligonucleotides corresponding to the two alleles at the two SNP loci into luciferase-expressing vectors. Plasmids containing the susceptible allele G for the SNP rs6841581, which showed higher binding affinity to the nuclear protein(s), revealed significantly lower luciferase activity than the non-susceptible allele A (Fig. 3C ), although no difference between the alleles was observed for the SNP rs1878406. It is notable that the non-susceptible allele A for rs6841581 revealed no enhancer activity in comparison with the mock (empty) vector, but plasmids containing the susceptible allele G revealed the suppressive effect on the activity (Fig. 3C) . Taking together, our findings from the EMSA and reporter assays suggest that the 5 ′ flanking region including the SNP rs6841581 on EDNRA might function as a transcriptional repressor and that this SNP is likely to be a functional variant conferring IA susceptibility.
DISCUSSION
To identify genetic variants associated with IA in the Japanese population, we performed a GWAS and a replication study with a total of 2431 aSAH/IA subjects and 12 696 control individuals. Among the identified SNPs, we did not observe significant differences in odds ratio (risk) between the aSAH patients in the discovery GWAS phase and the IA patients in the replication stage, indicating that the identified SNPs are likely to be associated with the risk of IA development.
The SNP rs6842241, which is located 1.25 kb upstream from the EDNRA gene encoding endothelin receptor A, revealed the most significant association with the combined P-value of 9.58 × 10
29
. Identification of this genetic variant in the regulatory region of EDNRA is clinically interesting since endothelin-1 (EDN-1) and its receptors, EDNRA and EDNRB, have been known to play a significant role in IA pathophysiology. EDN-1 is a potent vasoconstrictor produced by the endothelial cells in the vasculature system. The effect of EDN-1 is mediated by two major receptor subtypes, EDNRA and EDNRB, which activate a G-protein(s) and their second messenger system. EDNRA is located predominantly on vascular smooth muscle cells of the cerebrovascular system (22) and mediates vasoconstriction and proliferation (23) . Accumulated evidence strongly implies that the EDN-1/ EDNRA and EDNRB pathways are critically important to maintain the balance of vasoconstriction and vasodilatation in response to the hemodynamic stress. Previous reports suggested correlation of the elevated level of EDN-1 in the cerebrospinal fluid and plasma in patients with aSAH having persistent cerebral vasospasm (24, 25) . Interestingly, EDNRA variants were previously shown to be associated with a few cerebrovascular diseases including migraine (26) , myocardiac infarction (27, 28) and cystic fibrosis pulmonary disease (29) . Furthermore, EDNRA variants were also associated with essential hypertension (30) and it is overexpressed in the arteries of hypertensive patients (31) . The other three genes that reside at the same locus on chromosome 4q31.22 are PRMT10 with an unknown function; TMEM184C, which is a possible tumor suppressor that may play some role in cell growth (32); and ARHGAP10, which is a Rho GTPase-activating protein 10 which stabilizes PAK and stimulates cell death (33) . With strong biological evidence for the role of EDNRA in IA pathogenesis, we carried out functional analysis of the identified SNPs from the GWAS and imputation analyses. It is well known that SNPs located in the transcriptional regulatory regions such as promoter and enhancer regions could affect the expression levels of the gene product through alteration of the binding affinity to a specific transcription factor(s) (34) . The results of the EMSA and reporter assays indicated that the susceptible allele G of rs6841581 has higher affinity to the specific transcription factor(s) that might repress the transcriptional activity of EDNRA, compared with the nonsusceptible allele A. We observed a different binding affinity to a nuclear protein(s) between the two alleles of rs1878406, and the reporter assay revealed no effect on the transcriptional activity between them. We suspect it might reflect that the 31 bp oligonucleotides may not be long enough to cover the enhancer-or repressor-binding regions. The other possibility is that a nuclear protein bound to this region has no stronger effect on the transcriptional regulation.
For SNPs on chromosome 9p21.3, we successfully validated the association of this locus with IA as reported previously. We identified a stronger association of an SNP, rs10757272 (combined P ¼ 1.55 × 10 27 ), with IA than the SNP, rs1333040 (combined P ¼ 5.56 × 10
25
), that was previously identified in the study of the European population. Interestingly, the SNP rs10757272 was also shown to be associated with coronary artery disease (CAD) and platelet reactivity (a potential mechanism for increased vascular disease) in the European population (35, 36) . This finding suggests that rs10757272 or SNPs that are in high LD with it might be a common genetic risk factor(s) for multiple cardiovascular disorders. SNPs on a chromosome 9p21.3 region, which consist of p15
INK4b , p16 INK4a and CDKN2BAS, have been indicated to be associated with several atherosclerotic vascular diseases such as CADs (37) (38) (39) , stroke (40) , myocardial infarction (38) , abdominal aortic aneurysm (41) and IA (20) . A recent study revealed that targeted deletion of the 9p21 CAD risk interval in a mouse model resulted in severely attenuated expression of two CDKN2BASs' neighboring tumorsuppressor genes, p15
INK4b and p16 INK4a , which subsequently affects the CAD progression by altering the dynamics of vascular cell proliferation (42) . The findings of multiple vascular diseases associated with this locus have provided a new direction for the pathogenesis of these diseases.
Finally, although the association of rs671 (combined P ¼ 2.63 × 10
26
) on the ALDH2 gene was marginally replicated in this study, the association of this locus remained to be of interest in the Japanese population. ALDH2 belongs to the aldehyde dehydrogenase 2 family (mitochondrial), which is the second enzyme of the major oxidative pathway of alcohol metabolism. rs671 in this gene is the functional variant (Glu504Lys), and an A allele results in the inactivation of ALDH2, inducing 'alcohol flush'. The allelic frequency of this variant is uniquely high in the Asian population. In this study, the variant rs671A allele seemed to act as a protective allele, suggesting that individuals with the A allele might drink less amount of alcohol, which would result in the reduction of IA risk. Since alcohol drinking has been consistently indicated as one of the risk factors for IA, further validation of the association on this locus would be of medical importance. 2106 Human Molecular Genetics, 2012, Vol. 21, No. 9
In conclusion, by a large-scale GWAS, we successfully identified two genomic loci, EDNRA (4q31.22) and CDKN2BAS (9p21.3), to be significantly associated with IA in the Japanese population. Owing to the complexity of detecting IA in the general population, the associations of genetic variants have not just served as a promising prediction tool to identify individuals who have a higher risk of IA, but have also provided a better understanding of the disease pathogenesis which subsequently leads to the development of clinical intervention for IA.
MATERIALS AND METHODS

Study population
All DNA samples for this study were recruited from the Biobank Japan Project that began in 2003 (http://biobankjp. org). The Biobank Japan Project has a collaborative network of 66 hospitals throughout Japan to collect DNAs and serum samples from nearly 300 000 cases with any of the 47 diseases we assigned. One of the major aims of this project was to identify common genetic variants that confer risk to common diseases, including metabolic diseases and cancers. As a discovery step of this study, we selected 1383 patients registered as aneurysmal SAH (aSAH) cases, which is caused by the rupture of IA. We selected aSAH patients for the discovery screening because aSAH is a severe form of IA in which the disease-associated variants are likely to be enriched. We verified the association results of the first set by utilizing an independent set of samples consisting of 1048 IA patients. Identification of IA in the case samples was done using computerized tomography angiogram, magnetic resonance angiogram or cerebral digital subtraction angiogram. We included 5484 and 7212 controls consisting of healthy volunteers from Midosuji Rotary Club, Osaka, Japan, Health Science Research Resource Bank and individuals in the Biobank (B) The specific interaction of labeled oligonucleotides corresponding to alleles G and C was completed in a dose-dependent manner using an unlabeled oligonucleotide with the G and C alleles, but not oligonucleotides corresponding to the A and T alleles of rs6841581 and rs1878406, respectively. (C) Differences in the transcriptional activity between the susceptible and non-susceptible alleles of rs6841581 and rs1878406 measured by dual-luciferase reporter assay. The values of the relative luciferase activity are shown with standard deviation after normalization with internal control renilla luciferase activity. The relative luciferase activity of the susceptible genotype G of rs6841581 was significantly lower than that of the non-susceptible allele A and mock (empty) vector (P , 0.0001, Student's t-test).
Japan who were registered not to have SAH/IA in the discovery and replication stages, respectively. The detailed demographic and clinical parameters of cases and controls are summarized in Supplementary Material, Table S1 . Participants of this study provided written inform consent and this project was approved by the ethical committee from the Institute of Medical Sciences, the University of Tokyo and RIKEN Center of Genomic Medicine.
Genotyping and quality control
For the GWAS discovery stage, we genotyped both case and control samples using Illumina OmniExpress BeadChip that contained a total of 733 202 SNPs. We performed standard SNP quality control by excluding SNPs with a call rate of ,0.99, those deviated from the Hardy -Weinberg equilibrium (P ≤ 1.0 × 10
26
), non-polymorphic ones and those on the X chromosome. The cluster plots of top 100 SNPs that revealed the strongest association with aSAH were checked by visual observation to exclude SNPs with ambiguous patterns. The number of excluded SNPs in each quality control process is summarized in Supplementary Material, Table S2 . We utilized the identity-by-state method to evaluate cryptic relatedness for each sample; samples that possess an average estimate value of ≥1.7 were eliminated from subsequent analyses. Additionally, we examined population stratification by principal component analysis (PCA) using the EIGENSTRAT software v2.0 (http://genepath.med.harvard.edu/~reich/Software.htm). We first performed PCA, utilizing four populations in the HapMap database, which included Europeans (represented by Caucasian from UTAH, CEU), Africans (represented by Yoruba from Ibadan, YRI) and East Asians (represented by Japanese from Tokyo, JPT, and Han Chinese from Beijing, CHB) as reference populations for PCA. The top two principal components were utilized to produce a scatter plot for the identification of outliers who did not belong to the Asian cluster. To further investigate the population substructure in the sample population, we performed PCA using the genotype information of the case and control subjects in this study. The Q-Q plot that was generated between observed P-values against expected P-values and inflation factor (l) values were used to evaluate the potential population substructure. Manhattan plot of the study was plotted using Haploview 4.1 (43) .
For a replication study, a total of 36 SNPs that showed suggestive association with IA in the Japanese population (P GC , 1.0 × 10 24 ) as well as 7 SNPs that were previously reported to be associated with IA (19, 20) were selected for further evaluation with an independent set of 1048 IA cases and 7212 controls. We genotyped the cases with the multiplex-PCR Invader assay (44) and the control samples with Illumina OmniExpress BeadChip Kits. SNPs with a call rate of ,99% and those that were deviated from the Hardy -Weinberg equilibrium (P ≤ 0.05) were excluded for further analysis.
Statistical analysis
The case-control association was evaluated using logistic regression analysis with associated eigenvectors, age and gender as covariates in the discovery (GWAS) and replication phases of this study. The P-values obtained from the discovery phase were subsequently corrected using the genomic control method (45) , and the corrected P-values were used for further analysis. Meta-analysis for the combined analysis of discovery and replication phases was performed using the weighted inverse-variance method implemented in the METAL software (http://www.sph.umich.edu/csg/abecasis/Metal/index. html). P-values for the heterogeneity test are evaluated with Cochran's Q statistic and I 2 statistic (46). After the identification of candidate loci to be possibly associated with IA, imputation of the missing genotypes was performed with MACH 1.0 (http://www.sph.umich.edu/csg/abeca sis/MACH/index.html). For imputation analysis, we included SNPs that were located ,500 kb upstream or downstream of the marker SNP except SNPs that had a low genotyping rate (,99%), showed deviations from Hardy -Weinberg equilibrium (,1.0 × 10
26
) or had an MAF of ,0.01. Genotype information from the Phase III HapMap database was used as reference. Using the MACH version 1.0 program, we estimated haplotypes, map crossover and error rates using 50 iterations of the Markov chain Monte Carlo algorithm. For imputation quality control, we excluded SNPs with r 2 values of ,0.3. Regional association plots were generated using Locus Zoom (https://statgen.sph.umich.edu/locuszoom/ genform.php?type=yourdata).
Cell line
A human embryonic kidney cell line, HEK293, was purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). HEK293 cells were grown in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA; ATCC) supplemented with 10% bovine serum (GIBCO) and 1% antibiotic/antimycotic solution (Sigma-Aldrich, St Louis, MO, USA). The cells were maintained at 378C in atmospheres of humidified air with 5% CO 2 .
Electrophoretic mobility shift assay A nuclear fraction of HEK293 cells was extracted using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific). Thirty-one base pairs of sense and antisense oligonucleotides corresponding to the genomic sequence which contained the SNPs of interest (rs6841581, rs17612742, rs1878406 and rs6842241) were synthesized (Supplementary Material, Table S6 ) and labeled with the DIG Gel Shift kit, second generation (Roche), according to the manufacturer's protocol. The reaction was started with pre-incubation of labeled oligonucleotide with poly[d(I-C)] and poly-L-lysine, and 10 mg of nuclear extract from HEK293, for 20 min at 258C. For a competition assay, 5-fold, 25-fold or 50-fold excess of unlabeled oligonucleotide was added to nuclear extracts before adding the either of DIG-labeled probes. The protein -DNA complex was separated by electrophoresis on a 6% non-denaturing polyacrylamide gel with 0.5× Trisborate EDTA buffer and transferred onto a nylon membrane. The protein complexes were visualized by autoradiography. All EMSAs were repeated twice to check for reproducibility.
2108
Dual-luciferase reporter assays
To construct luciferase reporter plasmids containing the SNPs of interest (rs6841581 and rs1878406), SmaI and BglII restriction enzyme sites were added to the 31 bp oligonucleotides that were used as a probe in the EMSA assay and either of the annealed double-stranded oligonucleotides was inserted into the upstream of the luciferase reporter gene in the pGL3 promoter (Promega). The sequences of the constructs were verified using the ABI3730 Genetic Analyzer (Applied Biosystems). After 24 h incubation of HEK293 cells (2 × 10 4 ) on a 12-well plate, the cells were co-transfected with 400 ng of each reporter construct and 8 ng of the internal control pRL-TK (renilla luciferase), using the FuGene 6 transfection reagent (Roche). After 48 h incubation, the cells were lysed in passive lysis buffer and luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega). The results were normalized by renilla luciferase activity.
